Here, we performed an analysis on the role of FRMD5 in thyroid cancer specimens and cell lines, as we found significant discrepancies in FRMD5 expression between BRAF- and RET-mutated PTCs, as well other types of TCs (TCGA and microarray data analysis of clinical specimens). This evidence concerns the gene BRAF and thyroid cancer.